Somatic POLE proofreading domain mutation, immune response and prognosis in colorectal cancer: a retrospective, pooled biomarker study
Background<br/> Precision cancer medicine depends on defining distinct tumour subgroups using biomarkers that may occur at very modest frequencies. One such subgroup comprises patients with exceptionally mutated (ultramutated) cancers caused by mutations that impair DNA polymerase epsilon (POL...
Main Authors: | Domingo, E, Freeman-Mills, L, Rayner, E, Glaire, M, Briggs, S, Koelzer, V, Frangou, E, Dutton, P, Kerr, R, Kerr, D, Tomlinson, I, Church, D, EPICOLON consortium |
---|---|
פורמט: | Journal article |
יצא לאור: |
Lancet
2016
|
פריטים דומים
-
POLE proofreading domain mutation defines a subset of immunogenic colorectal cancers with excellent prognosis
מאת: Glaire, MA, et al.
יצא לאור: (2016) -
POLE proofreading mutation, immune response and prognosis in endometrial cancer
מאת: Van Gool, I, et al.
יצא לאור: (2015) -
POLE proofreading mutations elicit an anti-tumor immune response in endometrial cancer
מאת: Klenerman, P, et al.
יצא לאור: (2015) -
Adjuvant treatment for POLE proofreading domain-mutant cancers: sensitivity to radiotherapy, chemotherapy, and nucleoside analogues
מאת: Van Gool, I, et al.
יצא לאור: (2018) -
A panoply of errors: polymerase proofreading domain mutations in cancer
מאת: Rayner, E, et al.
יצא לאור: (2016)